APA (7th ed.) Citation

Gehin, J., Warren, D., Syversen, S., Lie, E., Sexton, J., Loli, L., . . . Goll, G. (2021). Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: Data from the NOR-DMARD study. Scandinavian Journal of Rheumatology, 50(6), 445. https://doi.org/10.1080/03009742.2021.1875040

Chicago Style (17th ed.) Citation

Gehin, JE, et al. "Serum Golimumab Concentration and Anti-drug Antibodies Are Associated with Treatment Response and Drug Survival in Patients with Inflammatory Joint Diseases: Data from the NOR-DMARD Study." Scandinavian Journal of Rheumatology 50, no. 6 (2021): 445. https://doi.org/10.1080/03009742.2021.1875040.

MLA (9th ed.) Citation

Gehin, JE, et al. "Serum Golimumab Concentration and Anti-drug Antibodies Are Associated with Treatment Response and Drug Survival in Patients with Inflammatory Joint Diseases: Data from the NOR-DMARD Study." Scandinavian Journal of Rheumatology, vol. 50, no. 6, 2021, p. 445, https://doi.org/10.1080/03009742.2021.1875040.